pancreatic ductal adenocarcinoma

You have access
Cytoplasmic-only Expression of Maspin Predicts Unfavorable Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
EI UCHINAKA, TOMOHIKO SAKABE, TAKEHIKO HANAKI, NARUO TOKUYASU, TERUHISA SAKAMOTO, SOICHIRO HONJO, YOSHIYUKI FUJIWARA and YOSHIHISA UMEKITA

Anticancer Research May 2021, 41 (5) 2543-2552; DOI: https://doi.org/10.21873/anticanres.15032
Open Access
Ephrin Receptor A4 Expression Enhances Migration, Invasion and Neurotropism in Pancreatic Ductal Adenocarcinoma Cells
SATORU FURUHASHI, YOSHIFUMI MORITA, SHINYA IDA, RYUTA MURAKI, RYO KITAJIMA, MAKOTO TAKEDA, HIROTOSHI KIKUCHI, YOSHIHIRO HIRAMATSU, MITSUTOSHI SETOU and HIROYA TAKEUCHI

Anticancer Research April 2021, 41 (4) 1733-1744; DOI: https://doi.org/10.21873/anticanres.14938
You have access
Prognostic Significance of Plasma Fibrinogen/Serum Albumin Ratio in the Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
KOICHI TOMITA, SHIGETO OCHIAI, TAKAHIRO GUNJI, KOSUKE HIKITA, TOSHIMICHI KOBAYASHI, TORU SANO, NAOKAZU CHIBA and SHIGEYUKI KAWACHI

Anticancer Research December 2020, 40 (12) 7017-7023; DOI: https://doi.org/10.21873/anticanres.14727
You have access
Protective Desmoplasia in Pancreatic Adenocarcinoma: High Vitamin D Receptor Expression and Collagen Content
ADI VAKNINE BAHAT, SHOSHI BAR-DAVID, ABIGAIL BROOKS, ASAF AIZIC, ORLI GREENBERG, IDO WOLF, JOSEPH M. KLAUSNER, GUY LAHAT and ERAN NIZRI

Anticancer Research November 2020, 40 (11) 6457-6464; DOI: https://doi.org/10.21873/anticanres.14667
You have access
A Blood-based Gene-expression Scoring System for Cancer Screening in Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms
REI SUZUKI, HIROSUMI TAMURA, REIKO HONMA, NAOKI KONNO, HIROKI IRIE, TADAYUKI TAKAGI, MITSURU SUGIMOTO, HIROYUKI ASAMA, YUKI SATO, OKUBO YOSHINORI, JUN NAKAMURA, MIKA TAKASUMI, TSUNETAKA KATO, MINAMI HASHIMOTO, TAKUTO HIKICHI, JUN-ICHI IMAI, SHINYA WATANABE and HIROMASA OHIRA

Anticancer Research November 2020, 40 (11) 6551-6561; DOI: https://doi.org/10.21873/anticanres.14680
You have access
Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
KAZUHIRO NAGAI, TOMOHIKO ADACHI, HIROSHI HARADA, SUSUMU EGUCHI, HARUO SUGIYAMA and YASUSHI MIYAZAKI

Anticancer Research October 2020, 40 (10) 5765-5776; DOI: https://doi.org/10.21873/anticanres.14593
You have access
Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells
EDGAR HEINZ UWE WENDT, MARIA SCHOENROGGE, BRIGITTE VOLLMAR and DIETMAR ZECHNER

Anticancer Research January 2020, 40 (1) 153-160; DOI: https://doi.org/10.21873/anticanres.13936
You have access
Towards a Personalized Approach in Pancreatic Cancer Diagnostics Through Plasma Amino Acid Analysis
JAROSLAV TUMAS, INGA BASKIROVA, TOMAS PETRENAS, JOLITA NORKUNIENE, KESTUTIS STRUPAS and AUDRIUS SILEIKIS

Anticancer Research April 2019, 39 (4) 2035-2042; DOI: https://doi.org/10.21873/anticanres.13314
You have access
Predictive Factors of Pancreatic Fistula After Pancreaticoduodenectomy and External Validation of Predictive Scores
MARCELLO DI MARTINO, ISMAEL MORA-GUZMAN, YAGO GARCÍA BLANCO-TRABA, MIGUEL CANTALEJO DÍAZ, MUHAMMAD ARSLAN KHURRAM and ELENA MARTÍN-PÉREZ

Anticancer Research January 2019, 39 (1) 499-504; DOI: https://doi.org/10.21873/anticanres.13140
You have access
A Phase I Study of S-1-based Concurrent Chemoradiotherapy Followed by Gemcitabine and S-1 in Metastatic Pancreatic Adenocarcinoma
SHIH-HUNG YANG, YU-YUN SHAO, CHIA-CHI LIN, SUNG-HSIN KUO, ANN-LII CHENG and KUN-HUEI YEH

Anticancer Research August 2018, 38 (8) 4805-4812; DOI: https://doi.org/10.21873/anticanres.12790

Main menu

User menu

Search

pancreatic ductal adenocarcinoma

Pages